| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0003 |